Cancer genetic association studies in the genome-wide age

Personalized Medicine

Volumn 5, Issue 6, 2008, Pages 589-597

  Savage, Sharon A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Cancer risk; Genome wide association study; Genomics; Population genetics; SNP

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2;

BREAST CANCER; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; COLORECTAL CANCER; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENE OVEREXPRESSION; GENE REPLICATION; GENE STRUCTURE; GENETIC ALGORITHM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HETEROZYGOSITY; HUMAN; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; NEUROBLASTOMA; POPULATION GENETICS; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; RISK ASSESSMENT; RNA TRANSLATION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

EID: 57749209328     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/17410541.5.6.589     Document Type: Review

References (80)

1. Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA: Environmental and chemical carcinogenesis. Semin. Cancer Biol. 14(6), 473-486 (2004).
2. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S: Human papillomavirus and cervical cancer. Lancet 370(9590), 890-907 (2007).
3. DePinho RA: The age of cancer. Nature 408(6809), 248-254 (2000).
4. Knudson AG Jr: Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA 68(4), 820-823 (1971).
5. Zhu L: Tumour suppressor retinoblastoma protein Rb: a transcriptional regulator. Eur. J. Cancer 41(16), 2415-2427 (2005).
6. Li FP, Fraumeni JF Jr: Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann. Intern. Med. 71(4), 747-752 (19691.
7. Sengupta S, Harris CC: p53: traffic cop at the crossroads of DNA repair and recombination. Nat. Rev. Mol. Cell Biol. 6(1), 44-55 (2005).
8. Malkin D, Li FP, Strong LC et al.: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250 (4985), 1233-1238 (1990).
9. Li FP, Fraumeni JF Jr, Mulvihill JJ et al.: A cancer family syndrome in twenty-four kindreds. Cancer Res. 48(18), 5358-5362 (1988).
10. Wang W: Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat. Rev. Genet. 8(10), 735-748 (2007).
11. Wooster R, Neuhausen SL, Mangion J et al.: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265(5181), 2088-2090 (1994).
12. Hall JM, Lee MK, Newman B et al.: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250(4988), 1684-1689 (1990).
13. The International HapMap Consortium: The International HapMap Project. Nature 426(6968), 789-796 (2003).
14. Eichler EE, Nickerson DA, Altshuler D et al.: Completing the map of human genetic variation. Nature 447(7141), 161-165 (2007).
15. Packer BR, Yeager M, Burdett L et al.: SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res. 34(Database issue), D617-D621 (2006).
16. Stram DO: Tag SNP selection for association studies. Genet. Epidemiol. 27(4), 365-374 (2004).
17. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Akshuler D: Efficiency and power in genetic association studies. Nat.Genet. 37(11), 1217-1223 (2005).
18. Savage SA, Abnet CC, Mark SD et al.: Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 13(12), 2251-2257 (2004).
19. Lee WP, Tai DI, Lan KH et al.: The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin. Cancer Res. 11(18), 6431-6441 (2005).
20. Ohyauchi M, Imatani A, Yonechi M et al.: The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 54(3), 330-335 (2005).
21. Taguchi A, Ohmiya N, Shirai K et al.: Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol. Biomarkers Prev. 14 (11 Pt 1), 2487-2493 (2005).
22. Savage SA, Hou L, Lissowska J et al.: Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol. Biomarkers Prev. 15(3), 589-591 (2006).
23. Garza-Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI, Flores-Gutierrez JP, Maldonado-Garza HJ, Perez-Perez GI: Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8-251 polymorphisms in the risk for the development of distal gastric cancer. BMC. Cancer 7, 70 (2007).
24. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K: A comprehensive review of genetic association studies. Genet. Med. 4(2), 45-61 (2002).
25. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33(2), 177-182 (2003).
26. Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U: Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 299(20), 2423-2436 (2008).
27. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N: Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl Cancer Inst. 96(6), 434-442 (2004).
28. Khoury MJ, Little J, Gwinn M, Ioannidis JP: On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. Int. J. Epidemiol. 36(2), 439-445 (2007).
29. Rebbeck TR, Martinez ME, Sellers TA, Shields PG, Wild CP, Potter JD: Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiol. Biomarkers Prev. 13(12), 1985-1986 (2004).
30. Boffetta P, McLaughlin JK, La Vecchia C, Tarone RE, Lipworth L, Blot WJ: False-positive results in cancer epidemiology: a plea for epistemological modesty. J. Natl Cancer Inst. 100(14), 988-995 (2008).
31. Ioannidis JP, Gwinn M, Little J et al.: A road map for efficient and reliable human genome epidemiology. Nat. Genet. 38(1), 3-5 (2006).
32. Hunter DJ, Thomas G, Hoover RN, Chanock SJ: Scanning the horizon: what is the future of genome-wide association studies in accelerating discoveries in cancer etiology and prevention? Cancer Causes Control 18(5), 479-484 (2007).
33. Amos CI: Successful design and conduct of genome-wide association studies. Hum. Mol. Genet. 16(Spec No. 2), R220-R225 (2007).
34. Hunter DJ, Kraft P: Drinking from the fire hose - statistical issues in genome wide association studies. N. Engl. J. Med. 357(5), 436-439 (2007).
35. Zanke BW, Greenwood CM, Rangrej J et al.: Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat. Genet. 39(8), 989-994 (2007).
36. Yeager M, Orr N, Hayes RB et al.: Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39(5), 645-649 (2007).
37. Schumacher FR, Feigelson HS, Cox DG et al.: A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res. 67(7), 2951-2956 (2007).
38. Gudmundsson J, Sulem P, Manolescu A et al.: Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet. 39(5), 631-637 (2007).
39. Eeles RA, Kote-Jarai Z, Giles GG et al.: Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet. 40(3), 316-321 (2008).
40. Ghoussaini M, Song H, Koessler T et al.: Multiple loci with different cancer specificities within the 8q24 gene desert. J. Natl Cancer Inst. 100(13), 962-966 (2008).
41. Hunter DJ, Kraft P, Jacobs KB et al.: A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 39(7), 870-874 (2007).
42. Easton DF, Pooley KA, Dunning AM et al.: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447(7148), 1087-1093 (2007).
43. Maris JM, Mosse YP, Bradfield JP et al.: Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. N. Engl. J. Med. 358(24), 2585-2593 (2008).
44. Li JZ, Absher DM, Tang H et al.: Worldwide human relationships inferred from genome-wide patterns of variation. Science 319(5866), 1100-1104 (2008).
45. Hughes AL, Welch R, Puri V et al.: Genome-wide SNP typing reveals signatures of population history. Genomics 92(1), 1-8 (2008).
46. Yu K, Wang Z, Li Q et al.: Population substructure and control selection in genome-wide association studies. PLoS one 3(7), E2551 (2008).
47. Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447(7145), 661-678 (2007).
48. Pharoah PD, Antoniou AC, Easton DF, Ponder BA: Polygenes, risk prediction, and targeted prevention of breast cancer. N. Engl. J. Med. 358(26), 2796-2803 (2008).
49. Savage SA, Greene MH: The evidence for prostate cancer risk loci at 8q24 grows stronger. J. Natl Cancer Inst. 99(20), 1499-1501 (2007).
50. Wang L, McDonnell SK, Slusser JP et al.: Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res. 67(7), 2944-2950 (2007).
51. Zheng SL, Sun J, Cheng Y et al.: Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J. Natl Cancer Inst. 99(20), 1525-1533 (2007).
52. Zheng SL, Sun J, Wiklund F et al.: Cumulative association of five genetic variants with prostate cancer. N. Engl J. Med. 358(9), 910-919 (2008).
53. Coates RJ, Khoury MJ, Gwinn M: Five genetic variants associated with prostate cancer. N. Engl. J. Med. 358(25), 2738 (2008).
54. Gelmann EP: Complexities of prostate-cancer risk. N. Engl. J. Med. 358(9), 961-963 (2008).
55. Eisinger F: Five genetic variants associated with prostate cancer. N. Engl. J. Med. 358(25), 2740-2741 (2008).
56. Gartner CE, Barendregt JJ, Hall WD: Five genetic variants associated with prostate cancer. N. EngL J. Med. 358(25), 2738-2739 (2008).
57. Janssens AC, van Duijn CM: Five genetic variants associated with prostate cancer. N. Engl. J. Med. 358(25), 2739 (2008).
58. Severi G, Byrnes GB, Hopper JL: Five genetic variants associated with prostate cancer. N. Engl. J. Med. 358(25), 2739-2740 (2008).
59. Thorat MA: Five genetic variants associated with prostate cancer. N. Engl. J. Med. 358(25), 2740 (2008).
60. Vickers A, Lilja H, Scardino P: Five genetic variants associated with prostate cancer. N. Engl. J. Med. 358(25), 2740 (2008).
61. Hunter DJ, Khoury MJ, Drazen JM: Letting the genome out of the bottle - will we get our wish? N. Engl. J. Med. 358(2), 105-107 (2008).
62. Greene MH, Piedmonte M, Alberts D et al.: A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study. Cancer Epidemiol. Biomarkers Prev. 17(3), 594-604 (2008).
63. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L: The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet. Med. 9(10), 665-674 (2007).
64. Easton DF, Pooley KA, Dunning AM et al.: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447(7148), 1087-1093 (2007).
65. Gold B, Kirchhoff T, Stefanov S et al.: Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc. Natl Acad. Sci. USA 105(11), 4340-4345 (2008).
66. Stacey SN, Manolescu A, Sulem P et al.: Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet. 39(7), 865-869 (2007).
67. Tomlinson I, Webb E, Carvajal-Carmona L et al.: A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet. 39(8), 984-988 (2007).
68. Tomlinson IP, Webb E, Carvajal-Carmona L et al.: A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat. Genet. 40(5), 623-630 (2008).
69. Broderick P, Carvajal-Carmona L, Pittman AM et al.: A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat. Genet. 39(11), 1315-1317 (2007).
70. Tenesa A, Farrington SM, Prendergast JG et al.: Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat. Genet. 40(5), 631-637 (2008).
71. Sakamoto H, Yoshimura K, Saeki N et al.: Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat. Genet. 40(6), 730-740 (2008).
72. Hung RJ, McKay JD, Gaborieau V et al.: A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452(7187), 633-637 (2008).
73. Thorgeirsson TE, Geller F, Sulem P et al.: A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452(7187), 638-642 (2008).
74. Amos CI, Wu X, Broderick P et al.: Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 40(5), 616-622 (2008).
75. Brown KM, Macgregor S, Montgomery GW et al.: Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat. Genet. 40(7), 817-818 (2008).
76. Gudmundsson J, Sulem P, Steinthorsdottir V et al.: Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against Type 2 diabetes. Nat. Genet. 39(8), 977-983 (2007).
77. Gudmundsson J, Sulem P, Rafnar T et al.: Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat. Genet. 40(3), 281-283 (2008).
78. Nam RK, Zhang WW, Loblaw DA et al.: A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer. Prostate Cancer Prostatic. Dis. 11(3), 241-246 (2007).
79. Duggan D, Zheng SL, Knowlton M et al.: Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J. Natl Cancer Inst. 99(24), 1836-1844 (2007).
80. Thomas G, Jacobs KB, Yeager M et al.: Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet. 40(3), 310-315 (2008).